Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users

Long-Term Efficacy and Safety of Zolpidem Extended-Release 12.5 mg, Administered 3 to 7 Nights Per Week for 24 Weeks, in Patients With Chronic Primary Insomnia: A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study

(2017) Andrew D. Krystal et al.   SLEEP

Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013

(2015) Deborah S. Hasin et al.   JAMA Psychiatry

Adverse Health Effects of Marijuana Use

(2014) Nora D. Volkow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse

(2013) Margaret Haney et al.   NEUROPSYCHOPHARMACOLOGY

Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: less can be more, more or less

(2012) Kathleen M. Carroll et al.   ADDICTION

A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers

(2012) Ziva D. Cooper et al.   ADDICTION BIOLOGY

Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers

(2012) Gillinder Bedi et al.   ADDICTION BIOLOGY

Predictors of Marijuana Relapse in the Human Laboratory: Robust Impact of Tobacco Cigarette Smoking Status

(2012) Margaret Haney et al.   BIOLOGICAL PSYCHIATRY

The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users

(2012) Ryan Vandrey et al.   DRUG AND ALCOHOL DEPENDENCE

Tolerance to Effects of High-Dose Oral Δ9-Tetrahydrocannabinol and Plasma Cannabinoid Concentrations in Male Daily Cannabis Smokers

(2012) David A. Gorelick et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Quantifying the Clinical Significance of Cannabis Withdrawal

(2012) David J. Allsop et al.   PLoS One

Efficacy of Eight Months of Nightly Zolpidem: A Prospective Placebo-Controlled Study

(2012) Surilla Randall et al.   SLEEP

Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal

(2011) Ryan Vandrey et al.   DRUG AND ALCOHOL DEPENDENCE

Separate and combined effects of the cannabinoid agonists nabilone and Δ9-THC in humans discriminating Δ9-THC

(2011) Joshua A. Lile et al.   DRUG AND ALCOHOL DEPENDENCE

Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial

(2011) Frances R. Levin et al.   DRUG AND ALCOHOL DEPENDENCE

Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study

(2011) Timothy A Roehrs et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The abuse potential of the synthetic cannabinoid nabilone

(2010) Mark A. Ware et al.   ADDICTION

Substitution Profile of the Cannabinoid Agonist Nabilone in Human Subjects Discriminating Δ9-Tetrahydrocannabinol

(2010) Joshua A. Lile et al.   CLINICAL NEUROPHARMACOLOGY

Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse

(2010) Margaret Haney et al.   PSYCHOPHARMACOLOGY

Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study

(2010) Gillinder Bedi et al.   PSYCHOPHARMACOLOGY

Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls

(2008) Margaret Haney   ADDICTION BIOLOGY

A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances

(2007) R.G. Vandrey et al.   DRUG AND ALCOHOL DEPENDENCE